Novartis gets FDA boost in crowded eye drug market
Reuters: Health
Novartis's anti-blindness medicine Beovu has become the latest eye drug to win U.S. Food and Drug Administration approval, giving the Swiss drugmaker a boost in the increasingly competitive market for eye problems among an ageing population.
Humira, Rituxan top list of U.S. drugs with biggest price increases: report
Reuters: Health
AbbVie Inc's arthritis drug Humira and Roche Holding AG's cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed.
Humira, Rituxan top list of U.S. costliest drug price increases - report
Reuters: Health
AbbVie Inc's arthritis drug Humira and Roche Holding AG's cancer drug Rituxan top the list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed.
Swedish hospital tests patient for Ebola, infection "unlikely"
Reuters: Health
A hospital in southern Sweden said on Tuesday it was testing a patient for Ebola who had come in with a fever after traveling in an infected area.